New One-Hour blood test could speed up heart attack diagnosis
NCT ID NCT03507270
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new one-hour diagnostic algorithm using a protein called FABP to quickly confirm or rule out a type of heart attack called NSTEMI. It involved 20 male patients who arrived at the hospital within 4 hours of chest pain. The goal was to see if measuring FABP levels could help doctors make faster decisions about treatment and hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fatty-acid-binding protein (FABP) diagnostic test
What this could lead to
If successful, this could lead to a faster, more accurate way to diagnose non-ST elevation heart attacks within one hour, helping doctors decide on treatment sooner.
What could go wrong
This is a very small pilot study with only 20 male participants, so results may not apply to women or larger populations. The test's accuracy is still uncertain and needs more research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiology Research Institute, Tomsk NRMC
Tomsk, 634012, Russia